Literature DB >> 10850458

Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis.

W H Park1, J G Seol, E S Kim, J M Hyun, C W Jung, C C Lee, B K Kim, Y Y Lee.   

Abstract

We investigated the in vitro effect of As2O3 on proliferation, cell cycle regulation, and apoptosis in human myeloma cell lines. As2O3 significantly inhibited the proliferation of all of eight myeloma cell lines examined in a dose-dependent manner with IC50 of approximately 1-2 microM. DNA flow cytometric analysis indicated that As2O3 (2 microM) induced a G1 and/or a G2-M phase arrest in these cell lines. To address the mechanism of the antiproliferative effect of As2O3, we examined the effect of As2O3 on cell cycle-related proteins in MC/CAR cells in which both G1 and G2-M phases were arrested. Western blot analysis demonstrated that treatment with As2O3 (2 microM) for 72 h did not change the steady-state levels of CDK2, CDK4, cyclin D1, cyclin E, and cyclin B1 but decreased the levels of CDK6, cdc2, and cyclin A. The mRNA and protein levels of CDKI, p21 were increased by treatment with As2O3, but those of p27 were not. In addition, As2O3 markedly enhanced the binding of p21 with CDK6, cdc2, cyclin E, and cyclin A compared with untreated control cells. Furthermore, the activity of CDK6-associated kinase was reduced in association with hypophosphorylation of Rb protein. The activity of cdc2-associated kinase was decreased, which was accompanied by the up-regulation of cdc2 phosphorylation (cdc2-Tyr15 phosphorylation) resulting from reduction of cdc25B and cdc25C phosphatases. As2O3 also induced apoptosis in MC/CAR cells as evidenced by flow cytometric detection of sub-G1 DNA content and annexin V binding assay. This apoptotic process was associated with down-regulation of Bcl-2, loss of mitochondrial transmembrane potential (delta psi(m)), and an increase of caspase-3 activity. These results suggest that As2O3 inhibits the proliferation of myeloma cells, especially MC/CAR cells, via cell cycle arrest in association with induction of p21 and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10850458

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  60 in total

1.  Efficacy and safety results with the combination therapy of arsenic trioxide, dexamethasone, and ascorbic acid in multiple myeloma patients: a phase 2 trial.

Authors:  Rony M Abou-Jawde; Janice Reed; Megan Kelly; Esteban Walker; Steven Andresen; Rachid Baz; Mary Ann Karam; Mohamad Hussein
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

2.  Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial.

Authors:  Muzaffar H Qazilbash; Rima M Saliba; Yago Nieto; Gaurav Parikh; Matteo Pelosini; Fatima B Khan; Roy B Jones; Chitra Hosing; Floralyn Mendoza; Donna M Weber; Michael Wang; Uday Popat; Amin Alousi; Paolo Anderlini; Richard E Champlin; Sergio Giralt
Journal:  Biol Blood Marrow Transplant       Date:  2008-12       Impact factor: 5.742

Review 3.  Arsenic trioxide - An old drug rediscovered.

Authors:  Ashkan Emadi; Steven D Gore
Journal:  Blood Rev       Date:  2010-05-15       Impact factor: 8.250

4.  IKK-β/NF-κB p65 mediates p27(Kip1) protein degradation in arsenite response.

Authors:  Wei Guo; Jinyi Liu; Jinlong Jian; Jingxia Li; Yu Wan; Chuanshu Huang
Journal:  Biochem Biophys Res Commun       Date:  2014-04-18       Impact factor: 3.575

5.  NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs).

Authors:  Daniella M B Kerbauy; Vladimir Lesnikov; Nissa Abbasi; Sudeshna Seal; Bart Scott; H Joachim Deeg
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

6.  Lycorine induces programmed necrosis in the multiple myeloma cell line ARH-77.

Authors:  Yuhao Luo; Mridul Roy; Xiaojuan Xiao; Shuming Sun; Long Liang; Huiyong Chen; Yin Fu; Yang Sun; Min Zhu; Mao Ye; Jing Liu
Journal:  Tumour Biol       Date:  2014-12-07

7.  Tetraarsenic oxide-mediated apoptosis in a cervical cancer cell line, SiHa.

Authors:  Jeong Kim; Su-Mi Bae; Dae-Seog Lim; Sun-Young Kwak; Chang-Ki Lee; Yong-Seok Lee; Il-Ju Bae; Jin-Young Yoo; Young-Joo Lee; Chong-Kook Kim; Woong-Shick Ahn
Journal:  Cancer Res Treat       Date:  2005-10-31       Impact factor: 4.679

8.  Arsenic exposure predicts bladder cancer survival in a US population.

Authors:  Ryan C Kwong; Margaret R Karagas; Karl T Kelsey; Rebecca A Mason; Sam A Tanyos; Alan R Schned; Carmen J Marsit; Angeline S Andrew
Journal:  World J Urol       Date:  2009-10-16       Impact factor: 4.226

9.  Basic mechanisms of arsenic trioxide (ATO)-induced apoptosis in human leukemia (HL-60) cells.

Authors:  Clement Yedjou; Paul Tchounwou; John Jenkins; Robert McMurray
Journal:  J Hematol Oncol       Date:  2010-08-26       Impact factor: 17.388

10.  Anticancer effect of realgar nanoparticles on mouse melanoma skin cancer in vivo via transdermal drug delivery.

Authors:  Qi-Hong Zhao; Ying Zhang; Yun Liu; Hui-Li Wang; Yuan-Yuan Shen; Wen-Jun Yang; Long-Ping Wen
Journal:  Med Oncol       Date:  2009-03-12       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.